FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Qualitest Pharmaceuticals Amlodipine Besylate Tablets Recall

AMLODIPINE BESYLATE TABLETS USP, 10 mg*, 1000 count bottles (NDC 0603-2110-32), Rx only…

Qualitest Pharmaceuticals · Huntsville, AL

Risk level
Class II
Reported by FDA
Mar 11, 2015
Recall ID
D-0397-2015
Check your lot numberHow we source this data

Summary

Qualitest Pharmaceuticals recalled Amlodipine Besylate Tablets starting Feb 13, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0397-2015 on Mar 11, 2015. Reason: Failed tablet specifications: One lot was found to contain oversized tablets. Status: Terminated.

Why it was recalled

Failed tablet specifications: One lot was found to contain oversized tablets.

Product description

AMLODIPINE BESYLATE TABLETS USP, 10 mg*, 1000 count bottles (NDC 0603-2110-32), Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811

Lot numbers, UPCs & expiration codes

Lot T018H14A, Exp 08/16

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0397-2015
Classification
Class II
Status
Terminated
Recall initiated
Feb 13, 2015
FDA report date
Mar 11, 2015
Quantity
2808 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Qualitest Pharmaceuticals

Original FDA data

Every field from FDA enforcement report D-0397-2015, exactly as published.

Show all FDA fields
City
Huntsville
State
AL
Status
Terminated
Country
United States
Event ID
70503
Address
120 Vintage Dr NE
Code information
Lot T018H14A, Exp 08/16
Postal code
35811-8216
Report date
Mar 11, 2015
Product type
Drugs
Recall number
D-0397-2015
Classification
Class II
Recalling firm
Qualitest Pharmaceuticals
Product quantity
2808 bottles
Termination date
Jan 27, 2016
Reason for recall
Failed tablet specifications: One lot was found to contain oversized tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
AMLODIPINE BESYLATE TABLETS USP, 10 mg*, 1000 count bottles (NDC 0603-2110-32), Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811
Distribution pattern
Nationwide
Recall initiation date
Feb 13, 2015
Initial firm notification
Letter
Center classification date
Mar 3, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0397-2015, published Mar 11, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls